Stiegler G - Search Results

1

Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10.

Mehandru S, Wrin T, Galovich J, Stiegler G, Vcelar B, Hurley A, Hogan C, Vasan S, Katinger H, Petropoulos CJ, Markowitz M. Mehandru S, et al. Among authors: stiegler g. J Virol. 2004 Dec;78(24):14039-42. doi: 10.1128/JVI.78.24.14039-14042.2004. J Virol. 2004. PMID: 15564511 Free PMC article.

2

Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12.

Wolbank S, Kunert R, Stiegler G, Katinger H. Wolbank S, et al. Among authors: stiegler g. J Virol. 2003 Apr;77(7):4095-103. doi: 10.1128/jvi.77.7.4095-4103.2003. J Virol. 2003. PMID: 12634368 Free PMC article.

3

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies.

Binley JM, Wrin T, Korber B, Zwick MB, Wang M, Chappey C, Stiegler G, Kunert R, Zolla-Pazner S, Katinger H, Petropoulos CJ, Burton DR. Binley JM, et al. Among authors: stiegler g. J Virol. 2004 Dec;78(23):13232-52. doi: 10.1128/JVI.78.23.13232-13252.2004. J Virol. 2004. PMID: 15542675 Free PMC article.

4

Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection.

Mehandru S, Vcelar B, Wrin T, Stiegler G, Joos B, Mohri H, Boden D, Galovich J, Tenner-Racz K, Racz P, Carrington M, Petropoulos C, Katinger H, Markowitz M. Mehandru S, et al. Among authors: stiegler g. J Virol. 2007 Oct;81(20):11016-31. doi: 10.1128/JVI.01340-07. Epub 2007 Aug 8. J Virol. 2007. PMID: 17686878 Free PMC article. Clinical Trial.

5

Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation.

Stiegler G, Armbruster C, Vcelar B, Stoiber H, Kunert R, Michael NL, Jagodzinski LL, Ammann C, Jäger W, Jacobson J, Vetter N, Katinger H. Stiegler G, et al. AIDS. 2002 Oct 18;16(15):2019-25. doi: 10.1097/00002030-200210180-00006. AIDS. 2002. PMID: 12370500 Clinical Trial.

6

Primary African HIV clade A and D isolates: effective cross-clade neutralization with a quadruple combination of human monoclonal antibodies raised against clade B.

Kitabwalla M, Ferrantelli F, Wang T, Chalmers A, Katinger H, Stiegler G, Cavacini LA, Chou TC, Ruprecht RM. Kitabwalla M, et al. Among authors: stiegler g. AIDS Res Hum Retroviruses. 2003 Feb;19(2):125-31. doi: 10.1089/088922203762688630. AIDS Res Hum Retroviruses. 2003. PMID: 12639248

7

Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.

Mascola JR, Lewis MG, VanCott TC, Stiegler G, Katinger H, Seaman M, Beaudry K, Barouch DH, Korioth-Schmitz B, Krivulka G, Sambor A, Welcher B, Douek DC, Montefiori DC, Shiver JW, Poignard P, Burton DR, Letvin NL. Mascola JR, et al. Among authors: stiegler g. J Virol. 2003 Oct;77(19):10348-56. doi: 10.1128/jvi.77.19.10348-10356.2003. J Virol. 2003. PMID: 12970419 Free PMC article.

8

Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine.

Ferrantelli F, Kitabwalla M, Rasmussen RA, Cao C, Chou TC, Katinger H, Stiegler G, Cavacini LA, Bai Y, Cotropia J, Ugen KE, Ruprecht RM. Ferrantelli F, et al. Among authors: stiegler g. J Infect Dis. 2004 Jan 1;189(1):71-4. doi: 10.1086/380102. Epub 2003 Dec 31. J Infect Dis. 2004. PMID: 14702155

9

Effects of antibody on viral kinetics in simian/human immunodeficiency virus infection: implications for vaccination.

Zhang L, Ribeiro RM, Mascola JR, Lewis MG, Stiegler G, Katinger H, Perelson AS, Davenport MP. Zhang L, et al. Among authors: stiegler g. J Virol. 2004 May;78(10):5520-2. doi: 10.1128/jvi.78.10.5520-5522.2004. J Virol. 2004. PMID: 15113932 Free PMC article.

10

Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies.

Ferrantelli F, Rasmussen RA, Buckley KA, Li PL, Wang T, Montefiori DC, Katinger H, Stiegler G, Anderson DC, McClure HM, Ruprecht RM. Ferrantelli F, et al. Among authors: stiegler g. J Infect Dis. 2004 Jun 15;189(12):2167-73. doi: 10.1086/420833. Epub 2004 May 26. J Infect Dis. 2004. PMID: 15181562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page